Pfizer Moderna Covid Vaccines
News

Number of COVID Vaccine Injuries Reported to VAERS Surpasses 50,000 Per CDC

Data released today by the Centers for Disease Control and Prevention (CDC) on the number of injuries and deaths reported to the Vaccine Adverse Event Reporting System (VAERS) following COVID vaccines revealed steadily rising numbers, but no new trends. VAERS is the primary mechanism for reporting adverse vaccine reactions in the U.S. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.

Every Friday, VAERS makes public all vaccine injury reports received to the system as of Friday of the previous week. Today’s data show that between Dec. 14,2020, and March 26, a total of 50,861 total adverse events were reported to VAERS, including 2,249 deaths — an increase of 199 over the previous seven days — and 7,726 serious injuries, up 631 over the same time period.

Of the 2,249 deaths reported as of March 26, 28% occurred within 48 hours of vaccination, 19% occurred within 24 hours and 43% occurred in people who became ill within 48 hours of being vaccinated.

In the U.S., 136.7 million COVID vaccine doses had been administered as of March 26.

From the 3-26-2021 release of VAERS data.

This week’s VAERS data show:

  • 19% of deaths were related to cardiac disorders.
  • 45% of those who died were male, 43% were female and the remaining death reports did not include gender of the deceased.
  • The average age of those who died was 77.7 and the youngest death was an 18-year-old.
  • As of March 26, 341 pregnant women had reported adverse events related to COVID vaccines, including 104 reports of miscarriage or premature birth.
  • Of the 578 cases of Bell’s Palsy reported, 63% of cases were reported after Pfizer-BioNTech vaccinations — almost twice as many as reported (36%) following vaccination with the Moderna vaccine. Seven cases of Bell’s Palsy were reported with Johnson & Johnson (J&J) vaccine (1%).
  • There were 2,578 reports of anaphylaxis, with 53% of cases attributed to the Pfizer-BioNTech vaccine, 44% to Moderna and 3% to J&J vaccine, which was rolled out in the U.S. on March 2.
  • Using a broadened search for any reference to anaphylaxis in chart notes resulted in 15,193 reports, with 52% of cases attributed to Pfizer’s COVID vaccine, 45% to Moderna and 3% to J&J. With each vaccine, nearly 42% of anaphylactic reports occurred in people aged 17-44.

More in:News

Leave a Comment